Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetohydroxyacid synthase (AHAS; also known as acetolactate synthase, ALS) is a thiamine diphosphate-dependent enzyme, classified as EC 2.2.1.6, and catalyzes the first common step in the biosynthesis of the branched-chain amino acids valine, leucine, and isoleucine. AHAS catalyzes the condensation of two pyruvate molecules (or pyruvate and 2-ketobutyrate) to give acetolactate (or acetohydroxybutyrate), precursors for these essential amino acids. This metabolic pathway is present in plants, fungi, archaea, and bacteria, but not in animals, making AHAS a major target for herbicides and a potential antibiotic target. The effectiveness of multiple classes of commercial herbicides is due to their selective inhibition of plant AHAS, enabling high crop-versus-weed selectivity and low animal toxicity. The enzyme consists of catalytic and regulatory subunits, requires thiamine pyrophosphate (TPP/ThDP) as a cofactor, and is highly conserved, with resistance mutations compromising herbicide efficacy increasingly reported in agricultural settings.
Competitive or noncompetitive inhibition of substrate binding at the ThDP (thiamine diphosphate) cofactor site; Occupation of active-site channel, blocking access of pyruvate and 2-ketobutyrate, leading to amino acid starvation in organisms reliant on the pathway; Certain herbicides also lead to cofactor degradation or inactivation (e.g., ThDP cleavage or modification)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetohydroxyacid synthase (AHAS).